Evotec SE (EVO) Earnings Date & Reports

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

EVO is expected to report earnings to fall 44.37% to -5 cents per share on August 13

Q2'25

Est.

$-0.06

Q1'25

Missed

by $0.09

Q4'24

Missed

by $0.09

Q3'24

Est.

$-0.12

Q2'24

Missed

by $0.26

The last earnings report on May 06 showed earnings per share of -10 cents, missing the estimate of -1 cents. With 11.66K shares outstanding, the current market capitalization sits at 2.77B.

View a ticker or compare two or three

Compare

EVO